Home » Topics » BioWorld Science

BioWorld Science
RSS

Burning Rock to support testing of Impact's ATR inhibitor IMP-9064

Nov. 4, 2021

SLC6A14 polymorphism tied to cystic fibrosis severity

Nov. 4, 2021

Defence Therapeutics' AccuVAC-PT001 COVID-19 vaccine completes toxicology studies in rabbits

Nov. 4, 2021

Versameb's VMB-100 shows promise for stress urinary incontinence in animal model

Nov. 4, 2021

RAPT Therapeutics patents USP7 inhibitors

Nov. 4, 2021

Discovery of novel IDO1 inhibitors for the treatment of cancer

Nov. 4, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical describes HBV antivirals

Nov. 4, 2021

Chinese researchers present new glucose-lowering agents

Nov. 4, 2021

Disarm Therapeutics discloses SARM1 inhibitors

Nov. 4, 2021

Keaise Medicine patents TRXR inhibitors

Nov. 4, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026